Client News

smartbax in-licenses lead antibacterial compound targeting Gram-negative infections from Aicuris

Andera Partners’ Portfolio Company Exciva Secures €51 Million Series B to Advance Clinical Program for Alzheimer’s-Related Agitation

DEBRA Research and the University Medical Center Groningen Launch Dedicated Clinical Trial Site for Epidermolysis Bullosa

AFYREN NEOXY: first significant revenue and growing production in 2025

Mainz Biomed to Present Results of Pancreatic Cancer Verification Study at AACR 2026 Annual Meeting

Peer-reviewed study demonstrates LEON’s FR-JET® modular mixer enables stable high-concentration mRNA-LNPs with enhanced in vivo activity

MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis

InflaRx Announces Strategy Focused on Capital-Efficient Execution with Izicopan and Near-Term Value Creation

Andera Partners co-leads $160 Million Series A round for Alveus to Advance Next-Generation Therapies for Obesity and Metabolic Diseases

VarmX and Rentschler Biopharma partner to advance novel coagulation therapy toward Phase 3 and commercialization